The American College of Rheumatology developed recommendations for decision-making to distinguish between the need for in-person urgent and virtual nonurgent medical care.
Italy’s health care system is highly regarded, having more hospital beds per capita than the United States.
Two-drug regimens are shown to be comparable with 3-drug regimens as viable clinical treatment options for HIV.
The transmission of direct-acting antiviral (DAA) resistance-associated substitutions (RAS) may inhibit hepatitis C virus (HCV) cure rates and elimination efforts.
Telmisartan did not affect biomarkers of central nervous system inflammation or injury when used as an adjunct to ART for acute HIV infection.
Effective 2-drug regimens may potentially decrease long-term exposure and toxicity with HIV-1 antiretroviral therapy.
Results from the DUALIS study demonstrated that dual therapy with dolutegravir and boosted darunavir tended to be an effective treatment option with no treatment-emergent resistance for people with HIV.
Women are less likely to be tested for HIV or offered prep at time of sexually transmitted infection diagnosis.
Dolutegravir (DTG)-based regimen may lead to significant improvement in blood lipid concentration, and no interference on glucose metabolism, but a relevant increase in trunk fat without alterations of body mass index (BMI) and body fat percent among youth with HIV. The results of this research were presented at the virtual Conference on Retroviruses and Opportunistic…
The increase in incidence of T1DM may not be solely a result of genetics and environmental factors, but also that of gut microbiota.
